dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma
NCT06609863
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Advanced Hepatocellular Carcinoma
Atezolizumab
Bevacizumab
Chemotherapy
Interventions
PROCEDURE:
dTACE-HAIC
Sponsor
Sun Yat-sen University